Soluble Interleukin-10 and Transforming Growth Factor-β in Children with Acute Exacerbation of Allergic Asthma

References

• Leff A R, Hamann K J, Wegner C D. Inflammation and cell-cell interaction in airway hyperresponsiveness. Am J Physiol 1991; 260: L189–206
   Google Scholar
• Walker C, Bode E, Boer L, Hansel T T, Blaser K, Virchow J C. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146: 109–115
   PubMed Web of Science ®Google Scholar
• Walker C, Virchow J C, Bruijnzeel P B, Blaser K. T cell subset and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991; 146: 1829–1835
   PubMed Web of Science ®Google Scholar
• Robinson D, Hamid Q, Bentley A, Ying S, Kay A B, Durham S R. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, k and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92: 313–324
   PubMed Web of Science ®Google Scholar
• Mark Larche. Regulatory T cells in allergy and asthma. Chest 2007; 132: 1007–1014
   PubMed Web of Science ®Google Scholar
• Cottrez F, Hurst S D, Coffman R L, Groux H. T regulatory cells 1 inhibits a Th2-specific response in vivo. J Immunol 2000; 165: 4848–4853
   PubMed Web of Science ®Google Scholar
• Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, Kegel C, Disch R, Schmidt-Weber C B, Blaser K, Akdis C A. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199: 1567–1575
   PubMed Web of Science ®Google Scholar
• Akdis C A, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of IL-10 in specific therapy. J Clin Invest 1998; 102: 98–106
   PubMed Web of Science ®Google Scholar
• Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis A C. IL-10 and TGF-β cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205–1214
   PubMed Web of Science ®Google Scholar
• Ling E M, Smith T, Nguyen X D, Pridgeon C, Dallman M, Arbery J, Carr V A, Robinson D S. Relation of CD4+DC25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 608–615
   PubMed Web of Science ®Google Scholar
• Grindebacke H, Wing K, Andersson A C, Suri-Payer E, Rak S, Rudin A. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004; 34: 1364–1372
   PubMed Web of Science ®Google Scholar
• Cosmic L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R, Lasagni L, Vanini V, Romagnani P, Maggi E, Annunziato F, Romagnani S. Th2 cells are less susceptible than Th2 cell to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 2004; 103: 3117–3121
   PubMedGoogle Scholar
• Espevik T, Figari I S, Shalaby M R, Lackides G A, Lewis G D, Shepard H M, Palladino M A, Jr. Inhibition of cytokine production by cyclosporine A and transforming growth factor beta. J Exp Med 1987; 166: 571–576
   PubMed Web of Science ®Google Scholar
• Brandes M E, Allen J B, Ogawa Y, Wahl S M. Transforming growth factor beta I suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991; 87: 1108–1113
   PubMed Web of Science ®Google Scholar
• Kuruvilla A P, Shah R, Hochwald G M, Liggitt H D, Palladino M A, Thorbecke G J. Protective effect of transforming growth factor beta I on experimental autoimmune disease in mice. Proc Natl Acad Sci USA 1991; 88: 2918–2921
   PubMed Web of Science ®Google Scholar
• Weiner H L. Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 1997; 48: 341–351
   PubMed Web of Science ®Google Scholar
• Hansen G, Mclntire J J, Yeung V P, Berry G, Thorbecke G J, Chen L, DeKruyff R H, Umetsu D T. CH4+ T helper cells engineered to produce latent TGF-β I reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000; 105: 61–70
   PubMed Web of Science ®Google Scholar
• Redington A E, Madden J, Freww A J, Djukanovic R, Roche W R, Holgate S T, Howaaeth P H. Transforming growth factor-β 1 in asthma: measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997; 156: 642–647
   PubMed Web of Science ®Google Scholar
• Chen Y, Juchroo V K, Inobe J, Hafler D A, Weiner H L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237–1240
   PubMed Web of Science ®Google Scholar
• Vignola A M, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca A M, Bellia V, Bonsignore G, Bousquet J. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 591–599
   PubMed Web of Science ®Google Scholar
• Hoshino M, Nakamura Y, Sim J J. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 1998; 53: 21–27
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Lijima K, Kita H. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 2003; 170: 5756–5763
   PubMedGoogle Scholar
• Ayanlar-Batuman O, Ferrero A P, Diaz A. Jimenez. Regulation of transforming growth factor-beta 1 gene expression by glucocorticosteroids in normal human T lymphocytes. J Clin Invest 1991; 88: 1574–1580
   PubMedGoogle Scholar
• Jeffery P K, Godfrey R W, Adelroth E, Nelson F, Rogers A, Johansson S A. Effects of treatment on airway inflammation and thickening of basement membranes reticular collagen layer. Am Rev Respir Dis 1992; 145: 890–899
   PubMed Web of Science ®Google Scholar
• Tournoy K G, Kip J C. Pauwels. Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin Exp Allergy 1999; 30: 775–783
   Google Scholar
• Shanley T P, Vasi N, Denenberg A. Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 2000; 12: 1054–1064
   PubMed Web of Science ®Google Scholar
• Robinson D S, Tsicopoulos A, Meng Q, Durham S, Kay A B, Hamid Q. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol 1996; 14: 113–117
   PubMedGoogle Scholar
• Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. 1996; 97: 1288–1296
   Google Scholar
• Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, Satoh K, Okamura K. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 1999; 14: 309–314
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Inoue H, Fukuyama S, Tsuda M, Ikegami T, Kibe A, Yoshiura Y, Komori M, Hamasaki N, Aizawa H, Nakanishi Y. Decrease of interleukin-10-producing T cells in the peripheral blood of severe unstable atopic asthmatics. Int Arch Allergy Immunol 2004; 134: 295–302
   PubMed Web of Science ®Google Scholar
• Barrat F J, Cua D J, Boonstra A, Richards D F, Crain C, Savelkoul H F, de Waal-Malefyt R, Coffman R L, Hawrylowicz C M, O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 2002; 195: 603–616
   PubMed Web of Science ®Google Scholar
• Karagiannidis C, Akdis M, Holopainen P, Woolley N J, Hense G, Rückert B, Mantel P Y, Menz G, Akdis C A, Blaser K, Schmidt-Weber C B. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425–1433
   PubMed Web of Science ®Google Scholar
• Kitani A, Fuss I, Nakamura K, Kumaki F, Usui T, Strober W. Transforming growth factor (TGF)- β 1-producting regulatory T cells induce Smad-medicated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-β 1-mediated fibrosis. J Exp Med 2003; 198: 1179–1188
   PubMed Web of Science ®Google Scholar